Overview
Howard Greenberg is a Hematologist in Greenlawn, New York. Dr. Greenberg is rated as an Experienced provider by MediFind in the treatment of Multiple Myeloma. His top areas of expertise are Myelodysplastic Syndrome (MDS), Thrombocytopenia, Idiopathic Neutropenia, and Essential Thrombocythemia.
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5 Cuba Hill Rd, Greenlawn, NY 11740
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Memorial Hematology Lymphoma Group
Saad Usmani is a Hematologist and an Oncologist in New York, New York. Dr. Usmani is rated as an Elite provider by MediFind in the treatment of Multiple Myeloma. His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.
New York University
Faith Davies is a Hematologist in New York, New York. Dr. Davies is rated as a Distinguished provider by MediFind in the treatment of Multiple Myeloma. Her top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration.
Memorial Hematology Lymphoma Group
Neha Korde is a Hematologist and an Oncologist in New York, New York. Dr. Korde is rated as an Elite provider by MediFind in the treatment of Multiple Myeloma. Her top areas of expertise are Smoldering Multiple Myeloma, Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Myelodysplastic Syndrome (MDS)Dr. Greenberg isDistinguished. Learn about Myelodysplastic Syndrome (MDS).
- Advanced
- Adult Immune ThrombocytopeniaDr. Greenberg isAdvanced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Greenberg isAdvanced. Learn about Agranulocytosis.
- Alpha ThalassemiaDr. Greenberg isAdvanced. Learn about Alpha Thalassemia.
- Alpha Thalassemia X-Linked Intellectual Disability Syndrome
- AnemiaDr. Greenberg isAdvanced. Learn about Anemia.
- B-Cell LymphomaDr. Greenberg isAdvanced. Learn about B-Cell Lymphoma.
- Experienced
- Acquired AgranulocytosisDr. Greenberg isExperienced. Learn about Acquired Agranulocytosis.
- Acute Eosinophilic PneumoniaDr. Greenberg isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Myeloblastic Leukemia with MaturationDr. Greenberg isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Greenberg isExperienced. Learn about Acute Myeloid Leukemia (AML).
- ALK-Positive Non-Small Cell Lung CancerDr. Greenberg isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.